OFIX
HealthcareOrthofix Medical Inc.
$11.71-0.32 (-2.62%)
Prev Close
$12.03
Open
$12.24
High
$12.24
Low
$11.68
Volume
161.2K
Market Cap
$502.2M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Orthofix Medical Inc. (OFIX) has been mixed between buying and selling, with 5 insider purchases totaling $2.00M and 18 insider sales totaling $1.32M. The most recent insider transaction was by CAPPS VICKIE L (director), who purchased $62.3K worth of shares on Mar 10, 2026. Orthofix Medical Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $502.2M.
Buys (12M)
5
$2.00M
Sells (12M)
18
$1.32M
Net Activity
Net Buyer
$680.0K
Active Insiders
12
last 12 mo
OFIX Price Chart
OFIX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026↗ | CAPPS VICKIE L | director | Buy | 5,000 | $12.46 | $62.3K | 27,585 |
| Mar 6, 2026↗ | Andrews Julie | officer: CFO | Sell | 4,788 | $12.74 | $61.0K | 91,109 |
| Mar 6, 2026↗ | Calafiore Massimo | director, officer: President & CEO | Sell | 12,220 | $12.74 | $155.6K | 326,167 |
| Mar 6, 2026↗ | Cedron Jorge Andres | officer: CLO | Sell | 2,775 | $12.74 | $35.3K | 64,119 |
| Mar 6, 2026↗ | Fisher Patrick | officer: President, Global Limb Recon | Sell | 1,536 | $12.74 | $19.6K | 51,391 |
| Mar 6, 2026↗ | McPherron Aviva | officer: Pres, Global Ops & Qual | Sell | 2,559 | $12.74 | $32.6K | 69,116 |
| Mar 6, 2026↗ | REINHARDT MAX | officer: President, Global Spine | Sell | 2,133 | $12.74 | $27.2K | 26,401 |
| Mar 6, 2026↗ | Vitale Lucas | officer: CP&BOO | Sell | 2,312 | $12.74 | $29.4K | 165,859 |
| Feb 26, 2026↗ | Engine Capital Management, LP | 10 percent owner | Buy | 137,858 | $12.59 | $1.73M | 3,673,090 |
| Jan 21, 2026↗ | Andrews Julie | officer: CFO | Sell | 4,873 | $14.38 | $70.1K | 58,039 |
| Jan 16, 2026↗ | Andrews Julie | CFO | Sell | 4,873 | $14.38 | $70.1K | 0 |
| Jan 13, 2026↗ | Calafiore Massimo | director, officer: President & CEO | Sell | 19,397 | $15.52 | $301.0K | 227,034 |
| Jan 9, 2026↗ | Calafiore Massimo | President & CEO | Sell | 19,397 | $15.52 | $301.0K | 0 |
| Aug 18, 2025↗ | Fisher Patrick | President, Global Orthopedics | Sell | 1,996 | $14.21 | $28.4K | 0 |
| Jun 18, 2025↗ | McPherron Aviva | Pres, Global Ops & Qual | Sell | 3,728 | $10.51 | $39.2K | 0 |
| Jun 11, 2025↗ | REINHARDT MAX | President, Global Spine | Sell | 1,643 | $11.64 | $19.1K | 0 |
| Jun 4, 2025↗ | Bazaar Alan Lee | Director | Buy | 2,250 | $10.92 | $24.6K | 0 |
| May 9, 2025↗ | Bazaar Alan Lee | Director | Buy | 3,990 | $12.60 | $50.3K | 0 |
| May 9, 2025↗ | Calafiore Massimo | President & CEO | Buy | 10,000 | $12.54 | $125.4K | 0 |
| Apr 16, 2025↗ | Cedron Jorge Andres | CLO | Sell | 3,816 | $13.31 | $50.8K | 0 |
| Apr 2, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 76 | $15.74 | $1.2K | 0 |
| Mar 18, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 296 | $16.60 | $4.9K | 0 |
| Mar 18, 2025↗ | Vitale Lucas | CP&BOO | Sell | 4,287 | $16.60 | $71.2K | 0 |
| Mar 5, 2025↗ | Calafiore Massimo | President & CEO | Buy | 9,914 | $17.43 | $172.8K | 0 |
| Feb 5, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 954 | $17.85 | $17.0K | 39,323 |
| Jan 21, 2025↗ | Andrews Julie | CFO | Sell | 4,655 | $17.89 | $83.3K | 28,312 |
| Jan 14, 2025↗ | Calafiore Massimo | President & CEO | Sell | 19,281 | $16.98 | $327.4K | 133,354 |
| Jan 14, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 475 | $16.98 | $8.1K | 40,317 |
| Jan 10, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 476 | $17.05 | $8.1K | 40,803 |
| Dec 19, 2024↗ | Gillespie Geoffrey C | CAO | Sell | 26 | $17.84 | $463.84 | 41,041 |
| Sep 14, 2023↗ | Hinrichs James F. | Director | Buy | 7,500 | $13.47 | $101.0K | 86,153 |
| May 26, 2023↗ | Kenny Kevin J. | President of Global Spine | Sell | 8,243 | $19.00 | $156.6K | 146,307 |
| Apr 5, 2023↗ | Maniar Shweta | Director | Sell | 4,262 | $17.75 | $75.7K | 20,080 |
| Nov 22, 2021↗ | Paolucci Michael E | Director | Buy | 2,000 | $31.15 | $62.3K | 27,141 |
| Nov 19, 2021↗ | BURZIK CATHERINE M | Director | Buy | 1,660 | $30.27 | $50.2K | 7,947 |
| Nov 19, 2021↗ | DOUG RICE | CFO | Buy | 1,400 | $30.05 | $42.1K | 73,543 |
| Nov 18, 2021↗ | Elting Kimberley A. | Chief Legal & Develop. Officer | Buy | 1,000 | $30.34 | $30.3K | 46,803 |
| Nov 18, 2021↗ | Serbousek Jon Carl | CEO | Buy | 1,670 | $31.14 | $52.0K | 112,812 |
OFIX Insider Buying Activity
The following table shows recent insider purchases of Orthofix Medical Inc. (OFIX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026↗ | CAPPS VICKIE L | director | Buy | 5,000 | $12.46 | $62.3K | 27,585 |
| Feb 26, 2026↗ | Engine Capital Management, LP | 10 percent owner | Buy | 137,858 | $12.59 | $1.73M | 3,673,090 |
| Jun 4, 2025↗ | Bazaar Alan Lee | Director | Buy | 2,250 | $10.92 | $24.6K | 0 |
| May 9, 2025↗ | Bazaar Alan Lee | Director | Buy | 3,990 | $12.60 | $50.3K | 0 |
| May 9, 2025↗ | Calafiore Massimo | President & CEO | Buy | 10,000 | $12.54 | $125.4K | 0 |
| Mar 5, 2025↗ | Calafiore Massimo | President & CEO | Buy | 9,914 | $17.43 | $172.8K | 0 |
| Sep 14, 2023↗ | Hinrichs James F. | Director | Buy | 7,500 | $13.47 | $101.0K | 86,153 |
| Nov 22, 2021↗ | Paolucci Michael E | Director | Buy | 2,000 | $31.15 | $62.3K | 27,141 |
| Nov 19, 2021↗ | BURZIK CATHERINE M | Director | Buy | 1,660 | $30.27 | $50.2K | 7,947 |
| Nov 19, 2021↗ | DOUG RICE | CFO | Buy | 1,400 | $30.05 | $42.1K | 73,543 |
| Nov 18, 2021↗ | Elting Kimberley A. | Chief Legal & Develop. Officer | Buy | 1,000 | $30.34 | $30.3K | 46,803 |
| Nov 18, 2021↗ | Serbousek Jon Carl | CEO | Buy | 1,670 | $31.14 | $52.0K | 112,812 |
OFIX Insider Selling Activity
The following table shows recent insider sales of Orthofix Medical Inc. (OFIX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026↗ | Andrews Julie | officer: CFO | Sell | 4,788 | $12.74 | $61.0K | 91,109 |
| Mar 6, 2026↗ | Calafiore Massimo | director, officer: President & CEO | Sell | 12,220 | $12.74 | $155.6K | 326,167 |
| Mar 6, 2026↗ | Cedron Jorge Andres | officer: CLO | Sell | 2,775 | $12.74 | $35.3K | 64,119 |
| Mar 6, 2026↗ | Fisher Patrick | officer: President, Global Limb Recon | Sell | 1,536 | $12.74 | $19.6K | 51,391 |
| Mar 6, 2026↗ | McPherron Aviva | officer: Pres, Global Ops & Qual | Sell | 2,559 | $12.74 | $32.6K | 69,116 |
| Mar 6, 2026↗ | REINHARDT MAX | officer: President, Global Spine | Sell | 2,133 | $12.74 | $27.2K | 26,401 |
| Mar 6, 2026↗ | Vitale Lucas | officer: CP&BOO | Sell | 2,312 | $12.74 | $29.4K | 165,859 |
| Jan 21, 2026↗ | Andrews Julie | officer: CFO | Sell | 4,873 | $14.38 | $70.1K | 58,039 |
| Jan 16, 2026↗ | Andrews Julie | CFO | Sell | 4,873 | $14.38 | $70.1K | 0 |
| Jan 13, 2026↗ | Calafiore Massimo | director, officer: President & CEO | Sell | 19,397 | $15.52 | $301.0K | 227,034 |
| Jan 9, 2026↗ | Calafiore Massimo | President & CEO | Sell | 19,397 | $15.52 | $301.0K | 0 |
| Aug 18, 2025↗ | Fisher Patrick | President, Global Orthopedics | Sell | 1,996 | $14.21 | $28.4K | 0 |
| Jun 18, 2025↗ | McPherron Aviva | Pres, Global Ops & Qual | Sell | 3,728 | $10.51 | $39.2K | 0 |
| Jun 11, 2025↗ | REINHARDT MAX | President, Global Spine | Sell | 1,643 | $11.64 | $19.1K | 0 |
| Apr 16, 2025↗ | Cedron Jorge Andres | CLO | Sell | 3,816 | $13.31 | $50.8K | 0 |
| Apr 2, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 76 | $15.74 | $1.2K | 0 |
| Mar 18, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 296 | $16.60 | $4.9K | 0 |
| Mar 18, 2025↗ | Vitale Lucas | CP&BOO | Sell | 4,287 | $16.60 | $71.2K | 0 |
| Feb 5, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 954 | $17.85 | $17.0K | 39,323 |
| Jan 21, 2025↗ | Andrews Julie | CFO | Sell | 4,655 | $17.89 | $83.3K | 28,312 |
| Jan 14, 2025↗ | Calafiore Massimo | President & CEO | Sell | 19,281 | $16.98 | $327.4K | 133,354 |
| Jan 14, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 475 | $16.98 | $8.1K | 40,317 |
| Jan 10, 2025↗ | Gillespie Geoffrey C | CAO | Sell | 476 | $17.05 | $8.1K | 40,803 |
| Dec 19, 2024↗ | Gillespie Geoffrey C | CAO | Sell | 26 | $17.84 | $463.84 | 41,041 |
| May 26, 2023↗ | Kenny Kevin J. | President of Global Spine | Sell | 8,243 | $19.00 | $156.6K | 146,307 |
| Apr 5, 2023↗ | Maniar Shweta | Director | Sell | 4,262 | $17.75 | $75.7K | 20,080 |
OFIX Insiders
Similar Stocks to OFIX
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B